Lipoatrophy Is the Predominant Presentation of HIV-Associated Lipodystrophy in Southern India

June 2004
Clinical Infectious Diseases;6/1/2004, Vol. 38 Issue 11, p1646
Academic Journal
At Yrg Care, a nonprofit organization and tertiary referral care center in southern India that provides medical and psychosocial care for nearly 4000 people living with HIV infection, all patients receiving antiretroviral therapy (ART) have had anthropometric measurements taken at each clinic visit, starting in January 2002. Among 286 patients receiving ART, researchers have identified 8 patients who developed lipoatrophy while receiving ART. As the number of patients receiving antiretroviral therapy increases in the developing world, and patients survive longer with HIV infection, prospective studies investigating metabolic and morphologic changes are needed to better understand regional differences in the risk factors for and presentation of HIV-associated lipodystrophy.


Related Articles

  • Self-reported signs of lipodystrophy by persons living with HIV infection. Dreezen, C.; Schrooten, W.; De Mey, I.; Goebel, F. D.; Dedes, N.; Florence, E.; Colebunders, R.; Eurosupport Study Group // International Journal of STD & AIDS;Jun2002, Vol. 13 Issue 6, p393 

    Objective: To identify risk factors for the development of lipodystrophy in HIV infected patients on highly active antiretroviral therapy.Methods: A survey among patients with HIV infection using an anonymous questionnaire was conducted in 10 European countries between...

  • DisfuncÈ›ia endotelială, lipodistrofia ÅŸi sindromul metabolic la pacienÈ›i infectaÈ›i cu HIV. PAPIȚĂ, ANAMARIA; ALBU, ADRIANA; ITU, CORINA; CÂRSTINA, D. // Romanian Journal of Medical Practice;2010, Vol. 5 Issue 3, p185 

    HIV infection has become in our days a chronic disease due to the efficiency of antiretroviral (ARV) treatment. Soon after the introduction of this treatment its complications related to metabolic disturbances have been observed and studied. Metabolic syndrome was particularly described in...

  • Lipodystrophy Severity Does Not Contribute to HAART Nonadherence. Collins, Evan J.; Burgoyne, Robert W.; Wagner, Cheryl A.; Abbey, Susan E.; Halman, Mark H.; Nur, Margaret L.; Walmsley, Sharon L. // AIDS & Behavior;May2006, Vol. 10 Issue 3, p273 

    Lipodystrophy severity among 77 people living with HIV/AIDS (PHA) with body fat redistribution was not related to antiretroviral adherence including doses missed during the previous month, categorical rating of maximal adherence, and the PMAQ7 adherence behavior scale. Two thirds of the sample...

  • Association between HLA-B*4001 and Lipodystrophy among HIV-Infected Patients from Thailand Who Received a Stavudine-Containing Antiretroviral Regimen. Wangsomboonsiri, Wittaya; Mahasirimongkol, Surakameth; Chantarangsu, Soranun; Kiertiburanakul, Sasisopin; Charoenyingwattana, Angkana; Komindr, Surat; Thongnak, Chupong; Mushiroda, Taisei; Nakamura, Yusuke; Chantratita, Wasun; Sungkanuparph, Somnuek // Clinical Infectious Diseases;2/15/2010, Vol. 50 Issue 4, p597 

    Background. Stavudine-containing antiretroviral regimens are widely used in developing countries. Stavudineassociated lipodystrophy commonly occurs, without a clear predictable pattern owing to the unknown interaction between stavudine and the host, among patients who received this regimen. The...

  • Effects of Lipodystrophy on Quality of Life and Depression in HIV-Infected Men on HAART. Steel, J. L.; Landsittel, D.; Calhoun, B.; Wieand, S.; Kingsley, L. A. // AIDS Patient Care & STDs;Aug2006, Vol. 20 Issue 8, p565 

    The aim of the study was a prospective assessment of the possible consequences of a diagnosis of lipodystrophy on health-related quality of life (HRQL) and depressive symptomatology in HIV-seropositive men who have sex with men. A standardized physical assessment for lipodystrophy was introduced...

  • The relationship between lipodystrophy-associated body changes and measures of quality of life and mental health for HIV-positive adults. Burgoyne, Robert; Collins, Evan; Wagner, Cheryl; Abbey, Susan; Halman, Mark; Nur, Margaret; Walmsley, Sharon // Quality of Life Research;May2005, Vol. 14 Issue 4, p981 

    Objectives: To investigate the relationship between lipodystrophy-specific symptom severity and wellbeing.Methods: HIV-positive adult patients with body fat redistribution (lipodystrophy syndrome) associated with antiretroviral therapy reported their total...

  • Patient Adherence To HAART Regimens: Challenges For Physician Assistants And Health Care Providers. Day, Marvin // Internet Journal of Academic Physician Assistants;2003, Vol. 3 Issue 1, p42 

    Patients often adhere incompletely and inadequately to highly active antiretroviral therapy (HAART) regimens used in the treatment of HIV infection. This permits the emergence of HIV variants that are resistant to current treatment. The physician assistant often assumes the responsibility for...

  • Dysregulated Energy Expenditure in HIV-Infected Patients: A Mechanistic Review. Chang, Evelyn; Sekhar, Rajagopal; Patel, Sanjeet; Balasubramanyam, Ashok // Clinical Infectious Diseases;6/1/2007, Vol. 44 Issue 11, p1509 

    Metabolic abnormalities are common in patients with human immunodeficiency virus (HIV) infection and range from protein catabolism to lipodystrophy and dyslipidemia associated with the use of highly active antiretroviral therapy. One abnormality is increased resting energy expenditure, which ...

  • Correction Options for Lipoatrophy in HIV-Infected Patients. Engelhard, Peter // AIDS Patient Care & STDs;Mar2006, Vol. 20 Issue 3, p151 

    Lipoatrophy (LA) is a form of lipodystrophy, characterized by volume depletion caused by fat loss in the limbs, buttocks, and face. Facial volume loss is the most obvious outward sign of LA because it alters the facial contours in the cheeks, temples, and orbits. Lipodystrophy and LA are most...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics